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Identity 
Other names: ID, bHLHb24 




DNA contains 1239 bp encoding 2 coding exons. 
Transcription 
Id1 gene has 2 transcripts, called Id1-001 (or Id1A) 
and Id-1-002 (or Id1B). mRNA Id1A contains 994 
bps whereas mRNA Id1B contains 1233 bps.  
Id1A is considered the "canonical sequence". 
Protein 
Description 
ID1 belongs to the helix-loop-helix protein family. It 
is composed by 155 aa.  
It has a main domain located on 143-155 aa 
responsible for the helix-loop-helix conformation.  
Its main motif, encoded by 14 aa is responsible for 
the nuclear export signaling. 
Expression 
High levels of ID1 are found in brain, liver, lung, skin 
and thyroid gland cells. It is also expressed in fetal 




Although it does not bind directly to DNA, by 
binding basic helix-loop-helix transcription factors 
through its HLH motif, ID1 may control tissue-
specific genes related to cell growth, proliferation, 
differentiation and angiogenesis. 
Homology 
H.sapiens: ID1; P.troglodytes: ID1; C.lupus: ID1; 
B.taurus: ID1; M.musculus: Id1; R.norvegicus: Id1; 
G.gallus: ID1; D.rerio: id1. 
Mutations 
Germinal 
No germinal mutations have been reported. 
Somatic 
No somatic mutations have been reported. 
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Implicated in 
Non small cell lung cancer 
Note 
ID1 levels are correlated with a worse prognosis in 
lung adenocarcinoma in both, disease free survival 
and overall survival. 
A higher expression of Id1 has been reported in 
squamous cell carcinoma and adenocarcinoma of the 
lung.  
ID1 expression are detected in more resistant tumors 
to either chemo and radiation therapy.  
When silencing Id1 in in vitro models, a reversal of 
resistance to the treatment (both chemotherapy and 
radiation) was observed. 
Gastric cancer 
Note 
Gastric cancer prognosis has also been linked to ID1 
expression levels.  
Whereas poor differentiated gastric tumors express 
higher levels of ID1, those gastric cancers with a 
higher differentiation, and thus, a better prognosis, 
express a lower quantity of ID1.  
Nevertheless, the impact of ID1 expression on 
clinical outcome has not reached statistical 




In breast cancer, especially in those node negative 
tumors, ID1 expression has become an independent 
prognostic factor.  
Higher levels of ID1 are related to a worse prognosis 
(measured by both, overall survival and disease free 
survival).  
This may be explained by the possible relation 
between ID1 and the steroid-receptor, this latter 
considered a factor which may change therapeutic 
options in breast cancer patients. 
Prostate cancer 
Note 
In prostate cancer it has been observed that levels of 
ID1 are correlated to the grade of differentiation 
measured by the Gleason score, detecting higher 
levels of ID1 in those prostate tumors with a higher 
Gleason score.  
Comparing prostate cancer with benign prostate 
hyperplasia, ID1 expression differences may also be 
seen; ID1 is not expressed in benign prostate 
hyperplasia (BPH), whereas ID1 expression is 
remarkably higher in prostate cancer cells. 
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Melanoma 
Note 
In melanoma ID1 is also positively related to tumor 
thickness and also with overall survival. Also, ID1 is 
highly expressed in those BRAF mutated melanomas 
compared to BRAF wild type melanomas. ID1 
negative regulates CDKN2A, which has been related 
to malignant melanoma development. ID1 is 
expressed in the earliest stages of melanoma. 
Glioblastoma 
Note 
In recent studies, ID1 has been catalogued as a 
marker of brain stem cells localized at the 
perivascular niche. Those stem cells with higher 
levels of ID1 have a major capability of tumor 
initiation and therapeutic resistance. 
Hepatocarcinoma 
Note 
In Hepatitis B virus-induced hepatocarcinoma, levels 
of ID1 may predict both disease free survival and 
overall survival, in a negative manner. Also, ID1 has 
been related to bad prognostic features such as portal 
vein invasion, lymph node metastasis and a worse 
Child Pugh grade. 
Anaplastic thyroid tumor 
Note 
ID1 is highly expressed in anaplastic thyroid tumors 
rather than in regular thyroid cells; it may be 




Lacking of Id1 alleles (with simultaneous Id3 
downregulation) triggers neural differentiation in 
mice embryos development resulting in a lethal event. 
It has also been reported that when Id1 and Id3 are 
not expressed, vascular sprouting in brain does not 
occur. 
Heart and vessel formation 
Note 
Id1 has also being related to play a crucial role in 
heart development, since Id1 knockout mice showed 
ventricular defects and myocardium trabeculation 
impairment.  
ID1 is also expressed in endothelial progenitor cells, 
and its suppression is related to angiogenesis 




Higher ID1 levels are found in pro-B cells, whereas it 
is downregulated in pre-B and mature cells. When 




Higher levels of ID1 expression are found in those 
breast cancers which are more prone to metastasize to 
the lung. Id1 has been described as part of the genes 
signature for breast cancer metastasis to the lung. 
Stemcellness and selfrenewal 
Note 
Satellite cells are muscle stem cells related to injured 
muscle renewal. ID1 expression has been recently 
correlated to muscle stem cell self-renewal ability, 
showing that when ID1 is expressed, a higher 
capability of self-renewal may be observed. Culture 
cells with high ID1 expression, may retain 
selfrenewal ability after several passages comparing 
to those cells with lower levels of ID1.  
Stem cells are characterized by their anchorage to an 
special microenviroment, also known as niche. ID1, 
by repressing the activation of Rap1GAP (an 
inhibitor of an important neural cell adhesion protein 
known as RAP1) assure stem cell joints to the niche. 
When ID1 is downregulated, neural stem cells detach 
from the brain stem cell niches, such as the 
ventricular zone in embryonic brain and the 
subventricular zone of post-nata brain. This 
detachment from the niches, may also trigger 
neuronal and oligodendrogial differentiation. 
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